Twist Bioscience Corp
For the period ended Sep 30, 2025. Filed Nov 17, 2025.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Nov 17, 2025
TWST$132.13-2.4%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Item 15. Exhibits, Financial Statement chedules
Documents filed as part of this report are as follows:
(a)Consolidated Financial Statements
Our Consolidated Financial Statements are included in the “Index to Consolidated Financial Statements” under Part II, Item 8 and filed as part of this Form 10-K.
(b)Consolidated Financial Statement Schedules
All financial statement schedules are omitted because the information called for is not required or is shown either in the consolidated financial statements or in the notes thereto.
(c)Exhibits
Set forth below is a list of exhibits that are being filed or incorporated by reference into this Form 10-K:
| ExhibitNumber | Description | Filed /Furnished /Incorporatedby Referencefrom Form | IncorporatedbyReferencefrom ExhibitNumber | Date Filed |
|---|---|---|---|---|
| 3.1 · Amended and Restated Certificate of Incorporation, as amended by the Certificate of Amendment to the Amended and Restated Certificate of Incorporation · Filed herewith | ||||
| 3.2 | Amended and Restated Bylaws | 8-K | 3.1 | 11/18/2022 |
| 4.1 | Form of common stock certificate | S-1/A | 4.1 | 10/17/2018 |
| 4.2 | Description of Common Stock | 10-K | 4.5 | 11/20/2020 |
| +10.1 | 2013 Stock Plan and forms of agreement thereunder | S-1 | 10.1 | 10/3/2018 |
| +10.2 | Amended and Restated 2018 Equity Incentive Plan and forms of agreement thereunder | 8-K | 10.2 | 2/11/2025 |
| +10.3 | 2018 Employee Stock Purchase Plan | S-1/A | 10.3 | 10/17/2018 |
| +10.4 | Executive Incentive Bonus Plan | S-1 | 10.4 | 10/3/2018 |
| +10.5 | Form of Indemnification Agreement between Twist Bioscience Corporation and each of its Officers and Directors | S-1/A | 10.8 | 10/17/2018 |
| +10.6 | Amended and Restated Inducement Equity Incentive Plan and related forms of award agreements thereunder | S-8 | 99.2 | 2/12/2025 |
| ExhibitNumber | Description | Filed /Furnished /Incorporatedby Referencefrom Form | IncorporatedbyReferencefrom ExhibitNumber | Date Filed |
|---|---|---|---|---|
| 10.7 | Lease Agreement by and between Twist Bioscience Corporation and ARE-San Francisco No. 32. LLC dated March 21, 2018 | S-1 | 10.11 | 10/3/2018 |
| 10.7.1 | First Amendment to Lease by and between Twist Bioscience Corporation and ARE-San Francisco No. 32, LLC, dated March 21, 2019 | 10-Q | 10.2 | 5/1/2019 |
| 10.7.2 | Second Amendment to Lease by and between Twist Bioscience Corporation and ARE-San Francisco No. 32, LLC, dated November 13, 2025 | Filed herewith | ||
| 10.8* | Lease Agreement by and between Twist Bioscience Corporation and PWII Owner, LLC, dated December 18, 2020 | 8-K | 10.1 | 12/22/2020 |
| 10.8.1* | First Amendment to Lease between Twist Bioscience Corporation and PWII Owner, LLC, dated April 13, 2021 | 8-K | 10.1 | 4/16/2021 |
| 10.9† | End User Supply Agreement by and between Twist Bioscience Corporation and FUJIFILM Dimatix, Inc., dated November 5, 2015 | S-1 | 10.14 | 10/3/2018 |
| +10.10 | Amended and Restated Employment Agreement dated October 26, 2022 between Twist Bioscience Corporation and Patrick Finn | 10-Q | 10.1 | 2/7/2023 |
| +10.11 | Employment Agreement dated December 18, 2023 between Twist Bioscience Corporation and Adam Laponis | 10-Q | 10.1 | 2/2/2024 |
| +10.12 | Amended and Restated Employment Agreement dated September 9, 2022 between Twist Bioscience Corporation and Emily Leproust | 10-K | 10.14 | 11/18/2024 |
| +10.13 | Amended and Restated Employment Agreement dated September 9, 2022 between Twist Bioscience Corporation and Paula Green | 10-K | 10.16 | 11/18/2024 |
| +10.14 | Amended and Restated Employment Agreement dated September 2, 2024 between Twist Bioscience Corporation and Dennis Cho | 10-K | 10.18 | 11/18/2024 |
| +10.15 | Employment Agreement dated April 24, 2023 between Twist Bioscience Corporation and Robert Werner | 10-K | 10.19 | 11/18/2024 |
| ExhibitNumber | Description | Filed /Furnished /Incorporatedby Referencefrom Form | IncorporatedbyReferencefrom ExhibitNumber | Date Filed |
|---|---|---|---|---|
| 10.16* | Contribution Agreement by and between Twist Bioscience Corporation and Altas Data Storage, Inc., dated May 2, 2025 | 10-Q | 10.1 | 8/4/2025 |
| 10.17* | License Agreement by and between Twist Bioscience Corporation and Atlas Data Storage, Inc., dated May 2, 2025 | 10-Q | 10.2 | 8/4/2025 |
| 10.18* | MES Software License Agreement by and between Twist Bioscience Corporation and Atlas Data Storage, Inc., dated May 2, 2025 | 10-Q | 10.3 | 8/4/2025 |
| 19.1 | Insider Trading Compliance Program | Filed herewith | ||
| 21.1 | List of subsidiaries of the Registrant | Filed herewith | ||
| 23.1 | Consent of Independent Registered Public Accounting Firm | Filed herewith | ||
| 31.1 | Certification pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, Rule 13(a)-14(a)/15d-14(a), by President and Chief Executive Officer | Filed herewith | ||
| 31.2 | Certification pursuant to Section 302 of the Sarbanes-Oxley Act of 2002, Rule 13(a)-14(a)/15d-14(a), by Chief Financial Officer | Filed herewith | ||
| 32.1 | Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, by President and Chief Executive Officer | Furnishedherewith | ||
| 32.2 | Certification pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, by Chief Financial Officer | Furnishedherewith | ||
| 97.1 | Compensation Recovery Policy | 10-K | 97.1 | 11/18/2024 |
| 101.INS | XBRL Instance Document | Filed herewith | ||
| ExhibitNumber | Description | Filed /Furnished /Incorporatedby Referencefrom Form | IncorporatedbyReferencefrom ExhibitNumber | Date Filed |
| 101.SCH | XBRL Taxonomy Extension Schema Document | Filed herewith | ||
| 101.CAL | XBRL Taxonomy Extension Calculation Linkbase Document | Filed herewith | ||
| 101.DEF | XBRL Taxonomy Extension Definition Linkbase Document | Filed herewith | ||
| 101.LAB | XBRL Taxonomy Extension Label Linkbase Document | Filed herewith | ||
| 101.PRE | XBRL Taxonomy Extension Presentation Linkbase Document | Filed herewith | ||
| 104 | Cover page from the Company’s Annual Report on Form 10-K for the year ended September 30, 2025, formatted in Inline XBRL | |||
- Indicates a management contract or compensatory plan.
| * | Registrant has omitted schedules and exhibits pursuant to Item 601(a)(5) of Regulation S-K. Registrant agrees to furnish supplementally a copy of the omitted schedules and exhibits to the SEC upon request. |
|---|
| † | Portions of this exhibit (indicated by asterisks) have been omitted pursuant to a request for confidential treatment that was separately filed with the SEC. |
|---|
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.